Skip to main content
2026 CRT Conference Main banner

CRT 2026

Artificial Intelligence and Digital Health

Session:: Artificial Intelligence and Digital Health [Non-CME]

Panel Discussion | Impact of AI Devices and LLMs in the Cath Lab

Monday, March 9, 2026
12:09 PM - 12:30 PM EST
Location: Cabinet

    Moderator(s)

  • Mona Advani, M.Sc., MBA

    Principal Regulatory Consultant
    CardioMed Device Consultants
    HERNDON, Virginia, United States

    Disclosure(s): No financial relationships to disclose

  • Richard E. Galgon, MD, MS

    Principal Consultant
    CardioMed Device Consultants, LLC
    Waunakee, Wisconsin, United States

    Disclosure(s): No financial relationships to disclose

    • Panel Discussant(s)

  • Jose M. De La Torre Hernandez, MD, PhD

    Interventional Cardiologist, Research Unit
    Hospital U. Marques de Valdecilla / IDIVAL
    Santander, Spain

    Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • JH

    Jackson Hair, PhD

    Biomedical Engineer
    FDA

    Disclosure(s): No financial relationships to disclose

  • Ramzi Khamis, MB, ChB, PhD, FRCP, FESC

    Professor of Cardiology. Consultant Cardiologist.
    Imperial College London and Imperial College Healthcare NHS Trust
    London, England, United Kingdom

    Disclosure(s): No financial relationships to disclose

  • Semih Oktay, PhD

    President
    Cardiomed Device Consultants
    Annapolis, Maryland, United States

    Disclosure(s): Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)

  • Robert-Jan M. van Geuns, MD, PhD

    Cardiologist
    RadboudUMC
    Nijmegen, Gelderland, Netherlands

    Disclosure(s): Abbott Vascular,: Grant/Research Support (Ongoing); InfraRedx: Grant/Research Support (Terminated, February 24, 2026), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, February 24, 2026)

Disclosure(s):
Mona Advani, M.Sc., MBA: No financial relationships to disclose
Richard E. Galgon, MD, MS: No financial relationships to disclose
Jose M. De La Torre Hernandez, MD, PhD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jackson Hair, PhD: No financial relationships to disclose
Ramzi Khamis, MB, ChB, PhD, FRCP, FESC: No financial relationships to disclose
Semih Oktay, PhD: Medical Device Manufacturers: I am a regulatory consultant to many cardiovascular device manufacturers (Ongoing)
Robert-Jan M. van Geuns, MD, PhD: Abbott Vascular,: Grant/Research Support (Ongoing); InfraRedx: Grant/Research Support (Terminated, February 24, 2026), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, February 24, 2026)